Bronchiectasis and inflammation – epidemiology, diagnosis and treatment in a nutshell - European Medical Journal

Bronchiectasis and inflammation – epidemiology, diagnosis and treatment in a nutshell

Respiratory

This podcast has been supported by CSL Behring.

Spotify | Apple | Amazon Music | Download MP3 (36:43 mins)

Bronchiectasis is a multifaceted condition with unique diagnostic and treatment considerations, presenting significant challenges for healthcare professionals. Join leading respiratory experts as they discuss bronchiectasis and the latest insights on managing inflammation in rare lung diseases.

 

Topics covered include:

  • Advances in the epidemiology of bronchiectasis and its prevalence in chronic obstructive pulmonary disease and alpha 1 antitrypsin deficiency
  • Recognising symptoms and identifying risk factors for recurrent exacerbations
  • Diagnostic approaches, including the use of CT scans and laboratory tests
  • Evidence-based treatment strategies and measures to prevent exacerbations

Speakers

Eva Polverino1

 

Marc Miravitlles2

 

Alice Turner3

 

Luca Richeldi4

 

1. Head of the Respiratory Infections Research Unit at the Vall d’Hebron University Hospital in Barcelona, Spain.
2. Senior Researcher and Consultant in the Pneumology Department also at the Vall d’Hebron University Hospital and the Vall d’Hebron Research Institute in Barcelona, Spain.
3. Consultant in Respiratory Medicine at Heartlands Hospital, University Hospitals Birmingham, and Professor of Respiratory Medicine at the University of Birmingham, UK.
4. Professor of Respiratory Medicine at the Catholic University of the Sacred Heart in Rome, Italy.

Moderator

Hannah Moir5

 

5. Head Medical Writer, Moderator, and Educator, EMJ, London, UK. Senior Fellow (Associate Professor in Health & Exercise Prescription), Faculty of Health, Science, Social Care and Education, Kingston University, London, UK.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.